Laurie Toich, Assistant Editor

Complementary health approaches for managing pain conditions may reduce opioid prescriptions.

Top news of the day from across the healthcare landscape.

Patient persistence with AirFluSal Forspiro was twice the rate of Seretide Diskus.

Affordable Care Act mandate requires most oral contraceptives to be fully covered without cost-sharing.

Recent analysis reveals the successes and disparities of the Affordable Care Act.

Repurposing a drug can potentially treat trypanosomiasis.

Sending graphs about antibiotic prescriptions reduced them going forward.

The impact of the Affordable Care Act on emergency department visits.

Top news of the day from across the healthcare landscape.

Development of odanacatib has been discontinued, and regulatory approval will not be sought.

Allergan acquired RetroSense Therapeutics and its gene therapy program for eye diseases.

A focus on customers and clinics added to pharmacies increased customer satisfaction with both mail order and retail pharmacies.

Treatment with edoxaban was as efficient as warfarin, but quicker.

Top news of the day from across the healthcare landscape.

Typically used to treat type 2 diabetes, metformin could slow heart disease development in patients with type 1 diabetes.

Little clinical data exists to aid shared decision making for mammography frequency.

Pharmacokinetics of anticoagulant tecarfarin not compromised by renal function as seen with warfarin.

The Centers for Medicare and Medicaid Services takes action to improve Affordable Care Act exchanges.

Researchers urge for more stringent guidelines regarding reimbursement for off-label use of cancer drugs.

Inhibition of a subunit of the nicotinic receptor showed protective effects against amyloid beta peptide.

Treatment with antipsychotics in patients with autism spectrum disorder can lead to a high body mass index.

National Institutes of Health to implement a plan to combat chronic diseases in disparate health populations.

Patients with negative expectations about breast cancer treatment had nearly twice the amount of side effects.

Mice treated with stem cells and 3K3A-APC had increased motor and sensory function.

Genetic mechanisms could potentially promote cancer growth and spread.

Tecentriq improved overall survival in patients with non-small cell lung cancer.

Warfarin may increase bleeding risk more than non-vitamin K antagonist oral anticoagulants.

Preschool-aged children who suffer a viral-triggered asthma attack have an increased chance of treatment failure.

Selumetinib did not meet trial endpoints in patients with KRASm-positive non-small cell lung cancer.

Transmission rates reduced 96% among couples who both received treatment.